Dr. Julian Wichmann is Co-Founder of Bloomwell Group and CEO of its subsidiary Algea Care, the first and leading platform for telemedicine-powered and evidence-based medical cannabis treatment in Germany.

He built Algea Care in 2020 to improve the available care for chronic pain and other diseases applying innovative solutions such as digitally accessible natural medicine. Prior to founding Bloomwell Group, Dr. Wichmann worked as a board-certified radiologist at a leading German university hospital and published over 150 original research papers.